Mental health policy; Role of psychiatric pharmacists and reimbursement for their services under Medicare; Enable access to mental health and substance use treatment services during COVID-19 pandemic; Remove barriers to pharmacists engagement in public health; Amend PREP Act to allow pharmacists to order and administer monoclonal antibodies for the treatment of COVID; Continuation of telehealth waivers through 2021, including audio only services and payment parity with in-person care.
Duration: January 6, 2017
to
January 14, 2022
General Issues: Health Issues , Budget/Appropriations , Medicare/Medicaid
Spending: about $400,000 (But it's complicated. Here's why.)
It can be tricky to figure out how much an organization spent on a particular lobbying engagement. The law only requires lobbyists to report the amount they were paid for federal lobbying each quarter rounded to the nearest $10,000—and if it's less than $3,000 in a given quarter (or less than $13,000 for organizations with in-house lobbyists), they don't have to disclose it at all. Plus, some organizations include spending that doesn’t belong in the report—for instance, money spent lobbying state governments or other legal work.
Agencies lobbied since 2017: U.S. Senate, House of Representatives, Centers For Medicare and Medicaid Services (CMS), Health & Human Services - Dept of (HHS), Office of Management & Budget (OMB)
Lobbyists
Lobbyists named here were listed on a filing related to this lobbying engagement. They may not be working on it now. Occasionally, a single lobbyist whose name is spelled two different ways on filings may be represented twice here.
Lobbyist
Covered positions?
Jeremy Scott Legislative Correspondent, Staff Assistant/Intern Coordinator, Health Care Intern for Senator Mike DeWine (OH)
Sarah Mills US Senate Committee on the Judiciary, Office of the Ranking Member- Legislative Aide; US Senate Committee on the Judiciary, Senator Flake- Special Legislative Aide
Laura Hanen n/a
Erin Prendergast n/a
Disclosures Filed
Once a lobbying engagement begins, the lobbyist or firm is required to file updates four times a year. Those updates sometimes change which lobbyists are involved or add new issues being discussed. When lobbyists stop working for a client, the firm is also supposed to file a report disclosing the end of the relationship.
1st Quarter, 2022
Faegre Drinker Biddle & Reath LLP terminated an engagement in which they represented College of Psychiatric and Neurologic Pharmacists on April 19, 2022.
Original Filing: 301361954.xml
Lobbying Issues
Mental health policy; Role of psychiatric pharmacists and reimbursement for their services under Medicare; Enable access to mental health and substance use treatment services during COVID-19 pandemic; Remove barriers to pharmacists engagement in public health; Amend PREP Act to allow pharmacists to order and administer monoclonal antibodies for the treatment of COVID; Continuation of telehealth waivers through 2021, including audio only services and payment parity with in-person care.
4th Quarter, 2021
In Q4, Faegre Drinker Biddle & Reath LLP lobbied for College of Psychiatric and Neurologic Pharmacists , earning $20,000. The report was filed on Jan. 11, 2022.
Original Filing: 301321214.xml
Lobbying Issues
Mental health policy; Role of psychiatric pharmacists and reimbursement for their services under Medicare; Enable access to mental health and substance use treatment services during COVID-19 pandemic; Remove barriers to pharmacists engagement in public health; Amend PREP Act to allow pharmacists to order and administer monoclonal antibodies for the treatment of COVID; Continuation of telehealth waivers through 2021, including audio only services and payment parity with in-person care; H.R. 721 - Mental Health Services for Students Act; H.R. 1384/S. 445 - Mainstreaming Addiction Act; H.R. 1475 - Pursuing Equity in Mental Health Act; H.R. 1205 - Improving Mental Health Access from the Emergency Department Act; H.R. 1480 - Helping Emergency Responders Overcome Act; H.R. 586 - STANDUP Act; H.R. 1364 - Parity Enforcement Act; H.R. 3753/S. 1962 - Parity Implementation Assistance Act; H.R. 1324/S. 467 - Effective Suicide Screening and Assessment in the Emergency Department Act; H.R. 2955 - Suicide Prevention Act; H.R. 2981 - Suicide Prevention Lifeline Improvement Act; H.R. 2862 - Campaign to Prevent Suicide Act; H.R. 909/S.484 - Moms Matter Act; H.R. 4323/S. 2069 - Excellence in Mental Health and Addiction Treatment Expansion; Providing guidance to schools on MH programming; Reducing barriers to use of PDMPs; Support for Miriam Delphin-Rittmon for Asst Secretary for MH and SU; Inclusion of pharmacists in Buprenorphine Practice Guidelines; Support removal of the X Waiver for MAT providers; 340B Drug Discount Program; H.R. 4217/S. 2779 - TRIUMPH for New Moms Act of 2021; H.R. 955/S. 285 - Medicaid Reentry Act of 2021; H.R. 4575/S. 2386 - Veteran Peer Specialist Act of 2021.
Agencies Lobbied
U.S. Senate
Lobbying Issues
FY 2022 Health and Human Services (HHS) appropriations funding for mental health programs; SAMHSA, CDC, and HRSA Title VII & Title VIII Behavioral Health Workforce Program; Funding for mental health and substance use programs; Funding to support the Crisis Continuum of Care, including suicide prevention; Funding to enforce mental health parity law; Funding for Infectious Diseases and Opioid Epidemic program.
Lobbying Issues
H.R. 955, S. 285 - Medicaid Reentry Act; Addressing Medicaid coverage gap.
3rd Quarter, 2021
In Q3, Faegre Drinker Biddle & Reath LLP lobbied for College of Psychiatric and Neurologic Pharmacists , earning $20,000. The report was filed on Oct. 18, 2021.
Original Filing: 301302626.xml
Lobbying Issues
Mental health policy; Role of psychiatric pharmacists and reimbursement for their services under Medicare; Enable access to mental health and substance use treatment services during COVID-19 pandemic; Remove barriers to pharmacists engagement in public health; Amend PREP Act to allow pharmacists to order and administer monoclonal antibodies for the treatment of COVID; Continuation of telehealth waivers through 2021, including audio only services and payment parity with in-person care; H.R. 721 - Mental Health Services for Students Act; H.R. 1384/S. 445 - Mainstreaming Addiction Act; H.R. 1475 - Pursuing Equity in Mental Health Act; H.R. 1205 - Improving Mental Health Access from the Emergency Department Act; H.R. 1480 - Helping Emergency Responders Overcome Act; H.R. 586 - STANDUP Act; H.R. 1364 - Parity Enforcement Act; H.R. 3753/S. 1962 - Parity Implementation Assistance Act; H.R. 1324/S. 467 - Effective Suicide Screening and Assessment in the Emergency Department Act; H.R. 2955 - Suicide Prevention Act; H.R. 2981 - Suicide Prevention Lifeline Improvement Act; H.R. 2862 - Campaign to Prevent Suicide Act; H.R. 909/S.484 - Moms Matter Act; H.R. 4323/S. 2069 - Excellence in Mental Health and Addiction Treatment Expansion; Providing guidance to schools on MH programming; Reducing barriers to use of PDMPs; Support for Miriam Delphin-Rittmon for Asst Secretary for MH and SU; Inclusion of pharmacists in Buprenorphine Practice Guidelines; Support removal of the X Waiver for MAT providers; 340B Drug Discount Program; H.R. 4217/S. 2779 - TRIUMPH for New Moms Act of 2021; H.R. 955/S. 285 - Medicaid Reentry Act of 2021; H.R. 4575/S. 2386 - Veteran Peer Specialist Act of 2021.
Lobbying Issues
FY 2022 Health and Human Services (HHS) appropriations funding for mental health programs; SAMHSA, CDC, and HRSA Title VII & Title VIII Behavioral Health Workforce Program; Funding for mental health and substance use programs; H.R. 2981/S. 2425 - Suicide Prevention Lifeline Improvement Act of 2021; Funding to enforce mental health parity law; Funding for CDC Community Violence Prevention Initiative.
Lobbying Issues
Increase in Federal Medical Assistance Percentages; H.R. 955/S. 285 - Medicaid Reentry Act; H.R. 3450/S. 1727 - Medicaid Bump Act.
2nd Quarter, 2021
In Q2, Faegre Drinker Biddle & Reath LLP (Formerly Known As Drinker Biddle & Reath LLP) lobbied for College of Psychiatric and Neurologic Pharmacists , earning $20,000. The report was filed on July 19, 2021.
Original Filing: 301283130.xml
Lobbying Issues
Mental health policy; Role of psychiatric pharmacists and reimbursements for the same; Enable access to mental health and substance use treatment services during COVID-19 pandemic; Remove barriers to pharmacists engagement in public health; Use Prep Act to engage retired pharmacists for COVID vaccinations; Continuation of telehealth waivers through 2021, including audio only services and payment parity with in-person care; H.R. 721 - Mental Health Services for Students Act; H.R. 1384/S. 445 - Mainstreaming Addiction Act; H.R. 1475 - Pursuing Equity in Mental Health Act; Mental Health Professionals Workforce Shortage Loan Repayment Act; H.R. 1205 - Improving Mental Health Access from the Emergency Department Act; H.R. 1480 - Helping Emergency Responders Overcome Act; H.R. 586 - STANDUP Act; H.R. 3150/S. 1578 - Mental Health Professionals Workforce Shortage Loan Repayment Act; H.R. 1364 - Parity Enforcement Act; H.R. 3753/S. 1962 - Parity Implementation Assistance Act; H.R. 1324/S. 467 - Effective Suicide Screening and Assessment in the Emergency Department Act; H.R. 2955 - Suicide Prevention Act; H.R. 2981 - Suicide Prevention Lifeline Improvement Act; H.R. 2862 - Campaign to Prevent Suicide Act; S. 1512 - CONNECT Act; H.R. 909/S.484 - Moms Matter Act; H.R. 2759/S. 1362 - Pharmacy and Medically Underserved Areas Enhancement Act; H.R. 4323/S. 2069 - Excellence in Mental Health and Addiction Treatment Expansion; Providing guidance to schools on MH programming; Reducing barriers to use of PDMPs; Support for Miriam Delphin-Rittmon for Asst Secretary for MH and SU; Inclusion of pharmacists in Buprenorphine Practice Guidelines; Support removal of the X Waiver for MAT providers; 340B Drug Discount Program.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
FY 2022 Health and Human Services (HHS) appropriations funding for mental health programs; SAMHSA, CDC, and HRSA Title VII & Title VIII Behavioral Health Workforce Program; Funding for mental health and substance use programs; American Rescue Plan.
Lobbying Issues
Increase in Federal Medical Assistance Percentages; H.R. 955/S. 285 - Medicaid Reentry Act; H.R. 3450/S. 1727 - Medicaid Bump Act.
1st Quarter, 2021
In Q1, Faegre Drinker Biddle & Reath LLP (Formerly Known As Drinker Biddle & Reath LLP) lobbied for College of Psychiatric and Neurologic Pharmacists , earning $20,000. The report was filed on April 19, 2021.
Original Filing: 301259081.xml
Lobbying Issues
Mental health policy; Role of psychiatric pharmacists and reimbursements for the same; Enable access to mental health and substance use treatment services during COVID-19 pandemic; Mental Health Justice Act; Remove barriers to pharmacists engagement in public health; Use Prep Act to engage retired pharmacists for COVID vaccinations; Add a pharmacist to the COVID-19 Health Equity Task Force; Continuation of telehealth waivers through 2021, including audio only services and payment parity with in-person care; H.R. 792 Barriers to Suicide Act; H.R. 953, Coronavirus Mental Health and Addiction Relief Act; S. 168 Temporary Reciprocity to Ensure Access to Treatment Act; H.R. 721 Mental Health Services for Students Act; H.R. 1384/S. 445 Mainstreaming Addiction Act; H.R. H.R. 1475 Pursuing Equity in Mental Health Act; S. 660 Telemental Health Improvement Act; H.R. 1716 COVID-19 Mental Health Research Act; Mental Health Professionals Workforce Shortage Loan Repayment Act.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
FY 2022 Health and Human Services (HHS) appropriations funding for mental health programs; SAMHSA, CDC, and HRSA Title VII & Title VIII Behavioral Health Workforce Program; Funding for mental health and substance use programs; American Rescue Plan.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Maintain six protected classes under Medicare Part D demo; Increase in Federal Medical Assistance Percentages; H.R. 955/S. 285 Medicaid Reentry Act.
Agencies Lobbied
U.S. House of Representatives
4th Quarter, 2020
In Q4, Faegre Drinker Biddle & Reath LLP (Formerly Known As Drinker Biddle & Reath LLP) lobbied for College of Psychiatric and Neurologic Pharmacists , earning $20,000. The report was filed on Jan. 18, 2021.
Original Filing: 301233769.xml
Lobbying Issues
Mental health policy; Role of psychiatric pharmacists and reimbursements for the same; Enable access to mental health and substance use treatment services during COVID-19 pandemic; H.R.4564 Suicide Prevention Lifeline Improvement Act; H.R.4585 Campaign to Prevent Suicide Act; H.R.4861/S.3006 Effective Suicide Screening and Assessment in the Emergency Department Act; H.R.5619/S.3198 Suicide Prevention Act; Make permanent telehealth flexibilities; Youth mental health policy issues; Mental Health Justice Act; S.1334/H.R.2519 - Improving Mental Health Access from the Emergency Department Act of 2020; S. 4338/H.R. 5469 Pursuing Equity in Mental Health Act; H.R.8639 Mental Health Justice Act of 2020; H.R. 2482/ S. 2074 Mainstreaming Addiction Act; S. 3999 Mental Health Connectivity Act; H.R. 7293/ S.2492 STANDUP Act; H.R.1646/S.3244 Helping Emergency Responders Overcome (HERO) Act; Continue teleprescribing of controlled substances through the end of 2021; Support for administration of injectable Medication Assisted Therapy by psychiatric pharmacists.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
FY 2021 Health and Human Services (HHS) appropriations funding for mental health programs; SAMHSA, CDC, and HRSA Title VII Behavioral Health Workforce Program; Funding for mental health and substance use programs in COVID relief packages; H.R. 133 the Consolidated Appropriations Act, 2021.
Lobbying Issues
I Medicaid coverage for those transitioning out of incarceration; Increase in Federal Medical Assistance Percentages; H.R. 1329 Medicaid Reentry Act.
3rd Quarter, 2020
In Q3, Faegre Drinker Biddle & Reath LLP (Formerly Known As Drinker Biddle & Reath LLP) lobbied for College of Psychiatric and Neurologic Pharmacists , earning $20,000. The report was filed on Oct. 17, 2020.
Original Filing: 301212503.xml
Lobbying Issues
Mental health policy; S.2661/H.R.4194 National Suicide Hotline Designation Act of 2019; Role of psychiatric pharmacists and reimbursements for the same; Enable access to mental health and substance use treatment services during COVID-19 pandemic; S. 2244/H.R. 4131 Improving Access to Remote Behavioral Health Treatment Act; 4th COVID-19 relief package to include: equitable coverage of teletherapy services under public and private ERISA plans during public health emergency; loosening of telehealth restrictions under TRICARE during public health emergency; H.R.4564 Suicide Prevention Lifeline Improvement Act; H.R.4585 Campaign to Prevent Suicide Act; H.R.4861/S.3006 Effective Suicide Screening and Assessment in the Emergency Department Act; H.R.5619/S.3198 Suicide Prevention Act; S. 2492/H.R.7293 Suicide Training and Awareness Nationally Delivered for Universal Prevention Act of 2019; H.R.1109/S.1122 Mental Health Services for Students Act; Funding for behavioral health and addiction providers and online peer support; H.R.6645 COVID-19 Mental Health Research Act; H.R.6720 Student Loan Forgiveness for Frontline Health Workers Act; Make permanent telehealth flexibilities; PREP Act declaration authorizing pharmacists to provide COVID-19 vaccines; Youth mental health policy issues; H.R.6720 Student Loan Forgiveness for Frontline Workers legislation; Mental Health Justice Act; S.1334/H.R.2519 - Improving Mental Health Access from the Emergency Department Act of 2020; S.1122/H.R.1109 - Mental Health Services for Students Act of 2020; S. 3825/H.R. 6999 Coronavirus Mental Health and Addiction Assistance Act; S. 4421 Temporary Reciprocity to Ensure Access to Treatment (TREAT Act); S. 4211 Facilitating Reforms that Offer Necessary Telehealth in Every Rural (FRONTIER) Community Act; Training for law enforcement on interactions with people with acute mental illness; S. Res 738 Designating September as National Suicide Prevention Month; S. 4338/H.R. 5469 Pursuing Equity in Mental Health Act.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
FY 2021 Health and Human Services (HHS) appropriations funding for mental health programs; SAMHSA, CDC, and HRSA Title VII Behavioral Health Workforce Program; H.R.6800 HEROES Act; Funding for mental health and substance use programs in 4th COVID relief packages-HR 925 HEROES Act and Senate Health, Economic Assistance, Liability Protection, and Schools Act.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Increase access to pharmacy services under Medicare in health professional shortage areas and medically underserved communities; Reimburse pharmacists on an emergency basis under Medicare Part B for COVID-19 and flu testing; H.R.6644, Health Care at Home Act; Medicaid coverage for those transitioning out of incarceration; S.3792 Tele-Mental Health Improvement Act of 2020; Increase in Federal Medical Assistance Percentages.
2nd Quarter, 2020
In Q2, Faegre Drinker Biddle & Reath LLP (Formerly Known As Drinker Biddle & Reath LLP) lobbied for College of Psychiatric and Neurologic Pharmacists , earning $20,000. The report was filed on July 17, 2020.
Original Filing: 301192313.xml
Lobbying Issues
Mental health policy; S.2661/H.R.4194 National Suicide Hotline Designation Act of 2019; Role of psychiatric pharmacists and reimbursements for the same; Enable access to mental health and substance use treatment services during COVID-19 pandemic; S. 2244/H.R. 4131 Improving Access to Remote Behavioral Health Treatment Act; 4th COVID-19 relief package to include: equitable coverage of teletherapy services under public and private ERISA plans during public health emergency; loosening of telehealth restrictions under TRICARE during public health emergency; H.R.4564 Suicide Prevention Lifeline Improvement Act; H.R.4585 Campaign to Prevent Suicide Act; H.R.4861/S.3006 Effective Suicide Screening and Assessment in the Emergency Department Act; H.R.5619/S.3198 Suicide Prevention Act; S. 2492/H.R.2599 Suicide Training and Awareness Nationally Delivered for Universal Prevention Act of 2019; H.R.1109/S.1122 Mental Health Services for Students Act; Funding for behavioral health and addiction providers and online peer support; S.3792 the Tele-Mental Health Improvement Act of 2020; H.R.6645 COVID-19 Mental Health Research Act; H.R.6644 Health Care at Home Act; H.R.6720 Student Loan Forgiveness for Frontline Health Workers Act; Make permanent telehealth flexibilities; PREP Act declaration authorizing pharmacists to provide COVID-19 vaccines; Youth mental health policy issues; H.R.6720 Student Loan Forgiveness for Frontline Workers legislation; H.R.6645 Covid-19 Mental Health Research Act.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
FY 2021 Health and Human Services (HHS) appropriations funding for mental health programs; SAMHSA, CDC, and HRSA Title VII Behavioral Health Workforce Program; H.R.6800 HEROES Act.
Lobbying Issues
Increase access to pharmacy services under Medicare in health professional shortage areas and medically underserved communities; Reimburse pharmacists on an emergency basis under Medicare Part B for COVID-19 and flu testing; H.R.6644, Health Care at Home Act; Medicaid coverage for those transitioning out of incarceration; S.3792 Tele-Mental Health Improvement Act of 2020; Increase in Federal Medical Assistance Percentages.
1st Quarter, 2020
In Q1, Faegre Drinker Biddle & Reath LLP (Formerly Known As Drinker Biddle & Reath LLP) lobbied for College of Psychiatric and Neurologic Pharmacists , earning $20,000. The report was filed on April 17, 2020.
Original Filing: 301169686.xml
Lobbying Issues
Mental health stigma; S.2661/H.R.4194 National Suicide Hotline Designation Act of 2019; Role of psychiatric pharmacists and reimbursements for the same; H.R. 4334 Supporting Older Americans Act of 2020; Enable access to mental health and substance use treatment services during COVID-19 pandemic; Increase access to pharmacy services under Medicare in health professional shortage areas and medically underserved communities; Reimburse pharmacists on an emergency basis under Medicare Part B for COVID-19 and flu testing; S. 2244/H.R. 4131 Improving Access to Remote Behavioral Health Treatment Act.
Lobbying Issues
FY 2021 Health and Human Services (HHS) appropriations funding for mental health programs.
4th Quarter, 2019
In Q4, DRINKER BIDDLE & REATH LLP lobbied for College of Psychiatric and Neurologic Pharmacists , earning $20,000. The report was filed on Jan. 17, 2020.
Original Filing: 301108460.xml
Lobbying Issues
Mental health stigma; S.2661/H.R.4194 National Suicide Hotline Designation Act of 2019; Role of psychiatric pharmacists and reimbursements for the same.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
FY 2020 Health and Human Services (HHS) appropriations funding for mental health programs.
3rd Quarter, 2019
In Q3, DRINKER BIDDLE & REATH LLP lobbied for College of Psychiatric and Neurologic Pharmacists , earning $20,000. The report was filed on Oct. 16, 2019.
Original Filing: 301066334.xml
Lobbying Issues
Mental health stigma; drug pricing.
Lobbying Issues
FY 2020 Health and Human Services (HHS) appropriations funding for mental health programs.
2nd Quarter, 2019
In Q2, DRINKER BIDDLE & REATH LLP lobbied for College of Psychiatric and Neurologic Pharmacists , earning $20,000. The report was filed on July 17, 2019.
Original Filing: 301047151.xml
Lobbying Issues
Provider status for pharmacists; drug pricing; Data waiver for pharmacists; H.R. 1884 Protecting Pre-Existing Conditions and Making Health Care More Affordable Act of 2019; H.R. 2482 Mainstreaming Addiction Treatment Act of 2019.
Agencies Lobbied
U.S. Senate
Lobbying Issues
FY 2020 Health and Human Services (HHS) appropriations funding for mental health programs.
1st Quarter, 2019
In Q1, DRINKER BIDDLE & REATH LLP lobbied for College of Psychiatric and Neurologic Pharmacists , earning $20,000. The report was filed on April 5, 2019.
Original Filing: 301022848.xml
Lobbying Issues
Provider status for pharmacists; drug pricing; H.R. The Medicaid Reentry Act; H.R. 838/ S. 265 The Treatment Assesment, Prevention, and Safety Act.
Agencies Lobbied
U.S. Senate
Lobbying Issues
FY 2020 Health and Human Services (HHS) appropriations funding for mental health programs.
4th Quarter, 2018
In Q4, DRINKER BIDDLE & REATH LLP lobbied for College of Psychiatric and Neurologic Pharmacists , earning $20,000. The report was filed on Jan. 16, 2019.
Original Filing: 301005153.xml
Lobbying Issues
S. 109/H.R. 592 The Pharmacy and Medically Underserved Areas Enhancement Act.
Agencies Lobbied
U.S. Senate
3rd Quarter, 2018
In Q3, DRINKER BIDDLE & REATH LLP lobbied for College of Psychiatric and Neurologic Pharmacists , earning $20,000. The report was filed on Oct. 18, 2018.
Original Filing: 300988046.xml
Lobbying Issues
Mental health issues; Opioid Issues; Draft opioid legislation; S. 2680 Opioid Crisis Response Act; HR. 6 Support for Patients and Communities Act; H.R.6597 Mental Health Professionals Workforce Shortage Loan Repayment Act.
Agencies Lobbied
U.S. Senate
Lobbying Issues
FY 2019 Health and Human Services (HHS) Appropriations supporting HRSA Title VII workforce programs.
2nd Quarter, 2018
In Q2, DRINKER BIDDLE & REATH LLP lobbied for College of Psychiatric and Neurologic Pharmacists , earning $20,000. The report was filed on July 17, 2018.
Original Filing: 300965962.xml
Lobbying Issues
Mental health issues; Opioid Issues; Draft opioid legislation; Including Families in Mental Health Recovery Act; S. 2524 Substance Use Disorder Workforce Loan Repayment Act of 2018; S. 2680 Opioid Crisis Response Act; HR. 6 Support for Patients and Communities Act.
Agencies Lobbied
U.S. Senate
Lobbying Issues
HR 592/ S. 109, Pharmacy and Medically Under-served Areas Enhancement Act; Letter to Sec. Azar regarding Part D's six protected classes.
Agencies Lobbied
U.S. Senate
1st Quarter, 2018
In Q1, DRINKER BIDDLE & REATH LLP lobbied for College of Psychiatric and Neurologic Pharmacists , earning $20,000. The report was filed on April 17, 2018.
Original Filing: 300945731.xml
Lobbying Issues
Mental health issues; Opioid Issues; House Ways and Means Committee letter on opioid crisis; finance committee letter on opioid crisis; HR 4778/ S. 2301, the Behavior Health Coverage Transparency Act; HR 3991, The Expanded Access to Opioid Abuse Treatment Act; HR 2345, the National Suicide Hotline Improvement Act; HR 5311/ S. 2456, the CARA 2.0 Act; HR 3692/ S 2317 Addiction Treatment Access Improvement Act.
Agencies Lobbied
U.S. Senate
Lobbying Issues
HR 592/ S. 109, Pharmacy and Medically Underserved Areas Enhancement Act.
Agencies Lobbied
U.S. Senate
Lobbying Issues
FY 2018 Appropriations (Consolidated Appropriation Act) related to health professions (HRSA Title VII) and opioids; FY 19 appropriation (LHHS) related to health professions (HRSA Title VII) and opioids.
4th Quarter, 2017
In Q4, DRINKER BIDDLE & REATH LLP lobbied for College of Psychiatric and Neurologic Pharmacists , earning $20,000. The report was filed on Jan. 17, 2018.
Original Filing: 300925484.xml
Lobbying Issues
Mental health issues; Opioid Issues
Agencies Lobbied
U.S. Senate
3rd Quarter, 2017
In Q3, DRINKER BIDDLE & REATH LLP lobbied for College of Psychiatric and Neurologic Pharmacists , earning $20,000. The report was filed on Oct. 12, 2017.
Original Filing: 300903121.xml
Lobbying Issues
Mental health issues; Opioid Issues
Agencies Lobbied
U.S. Senate
2nd Quarter, 2017
In Q2, DRINKER BIDDLE & REATH LLP lobbied for College of Psychiatric and Neurologic Pharmacists , earning $20,000. The report was filed on July 17, 2017.
Original Filing: 300886272.xml
Lobbying Issues
Mental health issues; Opioid Issues
Agencies Lobbied
U.S. Senate
1st Quarter, 2017
In Q1, DRINKER BIDDLE & REATH LLP lobbied for College of Psychiatric and Neurologic Pharmacists , earning $20,000. The report was filed on April 18, 2017.
Original Filing: 300867641.xml
Source: Clerk of the U.S. House of Representatives and Secretary of the Senate
Searching...